Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Invasive Meningococcal Disease due to Nongroupable Neisseria meningitidis-Active Bacterial Core Surveillance Sites, 2011-2016.

McNamara LA, Potts CC, Blain A, Topaz N, Apostol M, Alden NB, Petit S, Farley MM, Harrison LH, Triden L, Muse A, Poissant T, Wang X, MacNeil JR.

Open Forum Infect Dis. 2019 Apr 15;6(5):ofz190. doi: 10.1093/ofid/ofz190. eCollection 2019 May.

2.

University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013-2018.

Soeters HM, McNamara LA, Blain AE, Whaley M, MacNeil JR, Hariri S, Mbaeyi SA; Serogroup B Meningococcal Disease University Outbreak Group.

Emerg Infect Dis. 2019 Mar;25(3):434-440. doi: 10.3201/eid2503.181574.

3.

Meningococcal Disease Among College-Aged Young Adults: 2014-2016.

Mbaeyi SA, Joseph SJ, Blain A, Wang X, Hariri S, MacNeil JR.

Pediatrics. 2019 Jan;143(1). pii: e20182130. doi: 10.1542/peds.2018-2130. Erratum in: Pediatrics. 2019 May;143(5):.

PMID:
30598460
4.

Review of the economic evidence presented to the United States Advisory Committee on Immunization Practices, 2012-2016.

Pike J, Leidner AJ, MacNeil JR, Cohn AC.

Vaccine. 2019 Jan 3;37(1):7-10. doi: 10.1016/j.vaccine.2018.11.055. Epub 2018 Nov 23.

5.

Whole genome sequencing for investigations of meningococcal outbreaks in the United States: a retrospective analysis.

Whaley MJ, Joseph SJ, Retchless AC, Kretz CB, Blain A, Hu F, Chang HY, Mbaeyi SA, MacNeil JR, Read TD, Wang X.

Sci Rep. 2018 Oct 25;8(1):15803. doi: 10.1038/s41598-018-33622-5.

6.

Adoption of Serogroup B Meningococcal Vaccine Recommendations.

Kempe A, Allison MA, MacNeil JR, O'Leary ST, Crane LA, Beaty BL, Hurley LP, Brtnikova M, Lindley MC, Albert AP.

Pediatrics. 2018 Sep;142(3). pii: e20180344. doi: 10.1542/peds.2018-0344. Epub 2018 Aug 20.

7.

Emergence of Localized Serogroup W Meningococcal Disease in the United States - Georgia, 2006-2016.

Moore AE, MacNeil JR, Wang X, Joseph SJ, Lorentzson L, Thomas S, Tunali A, Parrott T, Farley MM, Tobin-D'Angelo M.

MMWR Morb Mortal Wkly Rep. 2018 Aug 17;67(32):894-897. doi: 10.15585/mmwr.mm6732a5.

8.

Epidemiology of Meningococcal Disease Outbreaks in the United States, 2009-2013.

Mbaeyi SA, Blain A, Whaley MJ, Wang X, Cohn AC, MacNeil JR.

Clin Infect Dis. 2019 Feb 1;68(4):580-585. doi: 10.1093/cid/ciy548.

PMID:
29982382
9.

Population structure of invasive Neisseria meningitidis in the United States, 2011-15.

Potts CC, Joseph SJ, Chang HY, Chen A, Vuong J, Hu F, Jenkins LT, Schmink S, Blain A, MacNeil JR, Harrison LH, Wang X.

J Infect. 2018 Nov;77(5):427-434. doi: 10.1016/j.jinf.2018.06.008. Epub 2018 Jun 30.

10.

Mass chemoprophylaxis for control of outbreaks of meningococcal disease.

McNamara LA, MacNeil JR, Cohn AC, Stephens DS.

Lancet Infect Dis. 2018 Sep;18(9):e272-e281. doi: 10.1016/S1473-3099(18)30124-5. Epub 2018 May 29. Review.

11.

Knowledge and Attitudes Regarding Category B ACIP Recommendations Among Primary Care Providers for Children.

Kempe A, Allison MA, MacNeil JR, O'Leary ST, Crane LA, Beaty BL, Hurley LP, Brtnikova M, Lindley MC, Liang JL, Albert AP, Smith JC.

Acad Pediatr. 2018 Sep - Oct;18(7):763-768. doi: 10.1016/j.acap.2018.04.005. Epub 2018 Apr 17.

12.

Expansion of a urethritis-associated Neisseria meningitidis clade in the United States with concurrent acquisition of N. gonorrhoeae alleles.

Retchless AC, Kretz CB, Chang HY, Bazan JA, Abrams AJ, Norris Turner A, Jenkins LT, Trees DL, Tzeng YL, Stephens DS, MacNeil JR, Wang X.

BMC Genomics. 2018 Mar 2;19(1):176. doi: 10.1186/s12864-018-4560-x.

13.

Meningococcal carriage among a university student population - United States, 2015.

Breakwell L, Whaley M, Khan UI, Bandy U, Alexander-Scott N, Dupont L, Vanner C, Chang HY, Vuong JT, Martin S, MacNeil JR, Wang X, Meyer SA.

Vaccine. 2018 Jan 2;36(1):29-35. doi: 10.1016/j.vaccine.2017.11.040. Epub 2017 Nov 26.

14.

Current Epidemiology and Trends in Meningococcal Disease-United States, 1996-2015.

MacNeil JR, Blain AE, Wang X, Cohn AC.

Clin Infect Dis. 2018 Apr 3;66(8):1276-1281. doi: 10.1093/cid/cix993.

PMID:
29126310
15.

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine.

McNamara LA, Topaz N, Wang X, Hariri S, Fox L, MacNeil JR.

MMWR Morb Mortal Wkly Rep. 2017 Jul 14;66(27):734-737. doi: 10.15585/mmwr.mm6627e1.

16.

Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine - Advisory Committee on Immunization Practices, 2016.

Patton ME, Stephens D, Moore K, MacNeil JR.

MMWR Morb Mortal Wkly Rep. 2017 May 19;66(19):509-513. doi: 10.15585/mmwr.mm6619a6.

17.

Increased Risk for Meningococcal Disease Among Men Who Have Sex With Men in the United States, 2012-2015.

Folaranmi TA, Kretz CB, Kamiya H, MacNeil JR, Whaley MJ, Blain A, Antwi M, Dorsinville M, Pacilli M, Smith S, Civen R, Ngo V, Winter K, Harriman K, Wang X, Bowen VB, Patel M, Martin S, Misegades L, Meyer SA.

Clin Infect Dis. 2017 Sep 1;65(5):756-763. doi: 10.1093/cid/cix438.

18.

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016.

Soeters HM, Dinitz-Sklar J, Kulkarni PA, MacNeil JR, McNamara LA, Zaremski E, Chang HY, Lujan E, Granoff D, Lasky M, Montana B.

Emerg Infect Dis. 2017 May;23(5):867-869. doi: 10.3201/eid2305.161870.

19.

Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.

Soeters HM, Whaley M, Alexander-Scott N, Kanadanian KV, MacNeil JR, Martin SW, McNamara LA, Sicard K, Vanner C, Vuong J, Wang X, Bandy U, Patel M; Rhode Island Meningococcal Carriage Evaluation Team.

Clin Infect Dis. 2017 Apr 15;64(8):1115-1122. doi: 10.1093/cid/cix091.

20.

Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine.

Cohn AC, MacNeil JR, Harrison LH, Lynfield R, Reingold A, Schaffner W, Zell ER, Plikaytis B, Wang X, Messonnier NE; Active Bacterial Core Surveillance (ABCs) Team and MeningNet Surveillance Partners.

Pediatrics. 2017 Feb;139(2). pii: e20162193. doi: 10.1542/peds.2016-2193.

21.

Meningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000-2008.

Harris CM, Wu HM, Li J, Hall HI, Lee A, Zell E, Harrison LH, Petit S, Farley MM, Lynfield R, Miller L, Nichols M, Reingold A, Schaffner W, Thomas A, MacNeil JR, Clark TA, Cohn AC.

Open Forum Infect Dis. 2016 Dec 20;3(4):ofw226. doi: 10.1093/ofid/ofw226. eCollection 2016 Oct.

22.

Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016.

MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IR, Martin SW.

MMWR Morb Mortal Wkly Rep. 2016 Nov 4;65(43):1189-1194. doi: 10.15585/mmwr.mm6543a3.

23.

Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009.

Blain AE, Mandal S, Wu H, MacNeil JR, Harrison LH, Farley MM, Lynfield R, Miller L, Nichols M, Petit S, Reingold A, Schaffner W, Thomas A, Zansky SM, Anderson R, Harcourt BH, Mayer LW, Clark TA, Cohn AC.

Open Forum Infect Dis. 2016 Jul 13;3(3):ofw152. eCollection 2016 Sep.

24.

Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.

MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW.

MMWR Morb Mortal Wkly Rep. 2015 Oct 23;64(41):1171-6. doi: 10.15585/mmwr.mm6441a3.

25.

Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States.

Harcourt BH, Anderson RD, Wu HM, Cohn AC, MacNeil JR, Taylor TH, Wang X, Clark TA, Messonnier NE, Mayer LW.

Open Forum Infect Dis. 2015 Aug 13;2(3):ofv117. doi: 10.1093/ofid/ofv117. eCollection 2015 Sep.

26.

Twenty Years of Active Bacterial Core Surveillance.

Langley G, Schaffner W, Farley MM, Lynfield R, Bennett NM, Reingold A, Thomas A, Harrison LH, Nichols M, Petit S, Miller L, Moore MR, Schrag SJ, Lessa FC, Skoff TH, MacNeil JR, Briere EC, Weston EJ, Van Beneden C.

Emerg Infect Dis. 2015 Sep;21(9):1520-8. doi: 10.3201/eid2109.141333.

27.

Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015.

Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR; Centers for Disease Control (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Jun 12;64(22):608-12. Erratum in: MMWR Morb Mortal Wkly Rep. 2015 Jul 31;64(29):806.

28.

First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak.

McNamara LA, Shumate AM, Johnsen P, MacNeil JR, Patel M, Bhavsar T, Cohn AC, Dinitz-Sklar J, Duffy J, Finnie J, Garon D, Hary R, Hu F, Kamiya H, Kim HJ, Kolligian J Jr, Neglia J, Oakley J, Wagner J, Wagner K, Wang X, Yu Y, Montana B, Tan C, Izzo R, Clark TA.

Pediatrics. 2015 May;135(5):798-804. doi: 10.1542/peds.2014-4015.

29.

Epidemiology of infant meningococcal disease in the United States, 2006-2012.

MacNeil JR, Bennett N, Farley MM, Harrison LH, Lynfield R, Nichols M, Petit S, Reingold A, Schaffner W, Thomas A, Pondo T, Mayer LW, Clark TA, Cohn AC.

Pediatrics. 2015 Feb;135(2):e305-11. doi: 10.1542/peds.2014-2035. Epub 2015 Jan 12.

30.

Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013.

MacNeil JR, Rubin L, McNamara L, Briere EC, Clark TA, Cohn AC; Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC.

MMWR Morb Mortal Wkly Rep. 2014 Jun 20;63(24):527-30.

31.

Neisseria meningitidis serogroup W, Burkina Faso, 2012.

MacNeil JR, Medah I, Koussoubé D, Novak RT, Cohn AC, Diomandé FV, Yelbeogo D, Kambou JL, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L, Hatcher C, Vuong J, Mayer LW, Djingarey MH, Clark TA, Messonnier NE.

Emerg Infect Dis. 2014 Mar;20(3):394-9. doi: 10.3201/eid2003.131407.

32.

A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups.

Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Mayer LW, Wang X, Macneil JR, York L, Tan CY, Jansen KU, Anderson AS.

Pediatr Infect Dis J. 2013 Oct;32(10):1096-101. doi: 10.1097/INF.0b013e31829aa63b.

PMID:
23694830
33.

Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States.

Mandal S, Wu HM, MacNeil JR, Machesky K, Garcia J, Plikaytis BD, Quinn K, King L, Schmink SE, Wang X, Mayer LW, Clark TA, Gaskell JR, Messonnier NE, DiOrio M, Cohn AC.

Clin Infect Dis. 2013 Aug;57(3):344-8. doi: 10.1093/cid/cit243. Epub 2013 Apr 17.

PMID:
23595832
34.

Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2013 Mar 22;62(RR-2):1-28.

35.

Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes.

Livorsi DJ, Macneil JR, Cohn AC, Bareta J, Zansky S, Petit S, Gershman K, Harrison LH, Lynfield R, Reingold A, Schaffner W, Thomas A, Farley MM.

J Infect. 2012 Dec;65(6):496-504. doi: 10.1016/j.jinf.2012.08.005. Epub 2012 Aug 15.

36.

Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009.

Briere EC, Jackson M, Shah SG, Cohn AC, Anderson RD, MacNeil JR, Coronado FM, Mayer LW, Clark TA, Messonnier NE.

Pediatrics. 2012 Sep;130(3):414-20. doi: 10.1542/peds.2012-0266. Epub 2012 Aug 6.

37.

Evaluation of new biomarker genes for differentiating Haemophilus influenzae from Haemophilus haemolyticus.

Theodore MJ, Anderson RD, Wang X, Katz LS, Vuong JT, Bell ME, Juni BA, Lowther SA, Lynfield R, MacNeil JR, Mayer LW.

J Clin Microbiol. 2012 Apr;50(4):1422-4. doi: 10.1128/JCM.06702-11. Epub 2012 Feb 1.

38.

Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008.

MacNeil JR, Cohn AC, Farley M, Mair R, Baumbach J, Bennett N, Gershman K, Harrison LH, Lynfield R, Petit S, Reingold A, Schaffner W, Thomas A, Coronado F, Zell ER, Mayer LW, Clark TA, Messonnier NE.

Clin Infect Dis. 2011 Dec;53(12):1230-6. doi: 10.1093/cid/cir735.

PMID:
22080119
39.

Meningococcal disease: shifting epidemiology and genetic mechanisms that may contribute to serogroup C virulence.

Macneil JR, Thomas JD, Cohn AC.

Curr Infect Dis Rep. 2011 Aug;13(4):374-9. doi: 10.1007/s11908-011-0195-7.

PMID:
21603878
40.

Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.

Wang X, Cohn A, Comanducci M, Andrew L, Zhao X, MacNeil JR, Schmink S, Muzzi A, Bambini S, Rappuoli R, Pizza M, Murphy E, Hoiseth SK, Jansen KU, Anderson AS, Harrison LH, Clark TA, Messonnier NE, Mayer LW.

Vaccine. 2011 Jun 24;29(29-30):4739-44. doi: 10.1016/j.vaccine.2011.04.092. Epub 2011 May 13.

PMID:
21571026
41.

Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine.

Macneil JR, Cohn AC, Zell ER, Schmink S, Miller E, Clark T, Messonnier NE; Active Bacterial Core surveillance (ABCs) Team and MeningNet Surveillance Partners.

Pediatr Infect Dis J. 2011 Jun;30(6):451-5. doi: 10.1097/INF.0b013e31820a8b3c.

PMID:
21206392
42.

Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.

Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, Pondo T, Arnold KE, Baumbach J, Bennett N, Craig AS, Farley M, Gershman K, Petit S, Lynfield R, Reingold A, Schaffner W, Shutt KA, Zell ER, Mayer LW, Clark T, Stephens D, Messonnier NE.

Clin Infect Dis. 2010 Jan 15;50(2):184-91. doi: 10.1086/649209.

PMID:
20001736
43.

Geographical differences in the occurrence of Alzheimer's disease mortality: United States versus Puerto Rico.

Figueroa R, Steenland K, MacNeil JR, Levey AI, Vega IE.

Am J Alzheimers Dis Other Demen. 2008 Oct-Nov;23(5):462-9. doi: 10.1177/1533317508321909.

44.

Evaluating loss to follow-up in newborn hearing screening in Massachusetts.

Liu CL, Farrell J, MacNeil JR, Stone S, Barfield W.

Pediatrics. 2008 Feb;121(2):e335-43. doi: 10.1542/peds.2006-3540. Epub 2008 Jan 10.

PMID:
18187812
45.

Evaluating families' satisfaction with early hearing detection and intervention services in Massachusetts.

MacNeil JR, Liu CL, Stone S, Farrell J.

Am J Audiol. 2007 Jun;16(1):29-56.

PMID:
17562754
46.

An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003.

MacNeil JR, Lobato MN, Moore M.

Am J Public Health. 2005 Oct;95(10):1800-5.

47.

Jails, a neglected opportunity for tuberculosis prevention.

MacNeil JR, McRill C, Steinhauser G, Weisbuch JB, Williams E, Wilson ML.

Am J Prev Med. 2005 Feb;28(2):225-8.

PMID:
15710280
48.

Towards more efficient practice: patients' records on tape.

Bayens JH, Macneil JR.

Can Fam Physician. 1971 Jul;17(7):59-60. No abstract available.

Supplemental Content

Loading ...
Support Center